Clinical studies of ABMT in acute myeloid leukaemia.

[1]  G. Meloni,et al.  Autologous bone marrow transplantation for acute leukaemia in remission , 1986, British journal of haematology.

[2]  G. Henze,et al.  Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78. , 1985, Blood.

[3]  J. Griffin,et al.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia. , 1985, The Journal of clinical investigation.

[4]  F. Mandelli,et al.  Cryopreserved autologous bone marrow infusion following high dose chemotherapy in patients with acute myeloblastic leukemia in first relapse. , 1985, Leukemia research.

[5]  B. Miller,et al.  The effect of natural killer cells on the development of syngeneic hematopoietic progenitors. , 1984, Journal of immunology.

[6]  J. Singer,et al.  The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. , 1984, Blood.

[7]  A. Burnett,et al.  TRANSPLANTATION OF UNPURGED AUTOLOGOUS BONE-MARROW IN ACUTE MYELOID LEUKAEMIA IN FIRST REMISSION , 1984, The Lancet.

[8]  R. Gale,et al.  HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA? , 1984, The Lancet.

[9]  J. Hermans,et al.  Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) , 1984, British journal of haematology.

[10]  G. Janossy,et al.  DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS , 1984, The Lancet.

[11]  B. Lowenberg,et al.  On the maturation order of AML cells: a distinction on the basis of self-renewal properties and immunologic phenotypes , 1984 .

[12]  N. Hogg,et al.  Monoclonal antibodies differentiating between monocytic and nonmonocytic variants of AML , 1984 .

[13]  A. Palumbo,et al.  Discrimination Between Normal Hemopoietic Stem Cells and Myeloid Leukemia Cells Using Monoclonal Antibodies , 1984 .

[14]  K. Foon,et al.  Acute myelogenous leukemia: current status of therapy in adults. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[15]  J. Griffin,et al.  Use of surface markers to identify a subset of acute myelomonocytic leukemia cells with progenitor cell properties. , 1983, Blood.

[16]  M. Fanger,et al.  Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia. , 1983, Blood.

[17]  Robert J. Mayer,et al.  Surface marker anaylsis of acute myeloblastic leukemia: identifi- cation of differentiation-associated phenotypes. , 1983 .

[18]  R. Gelber,et al.  Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update , 1983 .

[19]  R. Dinsmore,et al.  Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. , 1983, Blood.

[20]  A. Burnett,et al.  Haematological reconstitution following high dose and supralethal chemo‐radiotherapy using stored, non‐cryopreserved autologous bone marrow , 1983, British journal of haematology.

[21]  E. Vitetta,et al.  Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation. , 1983, Journal of immunology.

[22]  A. Burnett,et al.  T lymphocyte reconstitution following autologous bone marrow transplantation. , 1983, Clinical and experimental immunology.

[23]  E. Ronge-Collard,et al.  Granulocyte‐macrophage progenitor cell preservation at 4°C , 1983, British journal of haematology.

[24]  D. Linch,et al.  T cell regeneration after allogeneic and autologous bone marrow transplantation , 1982, British journal of haematology.

[25]  H. Gadner,et al.  Therapiestudie BFM 79/81 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: intensivierte Reinduktionstherapie für Patientengruppen mit unterschiedlichem Rezidivrisiko , 1982 .

[26]  B. Andersson,et al.  Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells. , 1982, Journal of immunology.

[27]  D. Rosenthal,et al.  The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia. , 1982, Cancer treatment reports.

[28]  M. Harada,et al.  Difference in posttransplant recovery of immune reactivity between allogeneic and autologous bone marrow transplantation. , 1982, Transplantation proceedings.

[29]  E. Klein,et al.  Specificity of auto‐tumor cytotoxicity exerted by fresh, activated and propagated human t lymphocytes , 1982, International journal of cancer.

[30]  R. Storb,et al.  Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. , 1982, International journal of radiation oncology, biology, physics.

[31]  K. Sullivan,et al.  Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. , 1982, Leukemia research.

[32]  E. McCulloch,et al.  Self-renewal capacity of leukemic blast progenitor cells. , 1981, Cancer research.

[33]  K. Sullivan,et al.  Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment , 1981 .

[34]  K. Sullivan,et al.  Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. , 1981, The New England journal of medicine.

[35]  J. Adamson,et al.  Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. , 1981, Blood.

[36]  K. Foon,et al.  Intensive chemotherapy for acute myelogenous leukemia. , 1981, Annals of internal medicine.

[37]  J. Petit,et al.  High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients. , 1981, European journal of cancer.

[38]  A. Mauer.  Therapy of Acute Lymphoblastic Leukemia in Childhood , 1980 .

[39]  D. Hedley,et al.  THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA , 1980, The Lancet.

[40]  E. Scott,et al.  Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. , 1980, The New England journal of medicine.

[41]  R. Winchester,et al.  Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells. , 1980, Blood.

[42]  P. Neiman,et al.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.

[43]  D. Hedley,et al.  Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. , 1979, British Journal of Cancer.

[44]  R. Storb,et al.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. , 1979, The New England journal of medicine.

[45]  H. Withers,et al.  Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation. , 1979, Radiology.

[46]  L. Peters,et al.  AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIA , 1979, The Lancet.

[47]  R. Abrams,et al.  The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms. , 1979, Cancer treatment reports.

[48]  E. Henderson,et al.  Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. , 1979, Blood.

[49]  W. Robinson,et al.  Liquid storage of bone marrow. , 1979, Experimental hematology.

[50]  D. Peakman,et al.  REMISSION OF RELAPSED LEUKÆMIA DURING A GRAFT-VERSUS-HOST REACTION A "GRAFT-VERSUS-LEUKÆMIA REACTION" IN MAN? , 1978, The Lancet.

[51]  J. Rees,et al.  D.A.T. (DAUNORUBICIN, CYTARABINE, 6-THIOGUANINE) IN ACUTE MYELOID LEUKÆMIA , 1978, The Lancet.

[52]  N. Gorin,et al.  Long-term preservation of bone marrow and stem cell pool in dogs. , 1978, Blood.

[53]  M. Greaves,et al.  Murine pluripotential stem cells lack Ia antigen , 1977, Nature.

[54]  M. Albala,et al.  Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice. , 1977, Cancer research.

[55]  P. Neiman,et al.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.

[56]  F. Bach,et al.  Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells , 1976, Nature.

[57]  A. Rimm,et al.  Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice. , 1975, Journal of the National Cancer Institute.

[58]  M. Albala,et al.  Graft versus leukemia without fatal graft-versus-host disease in AKR mice. , 1975, Cancer research.

[59]  A. Rimm,et al.  GRAFT VERSUS LEUKEMIA: III. Apparent Independent Antihost and Antileukemic Activity of Transplanted Immunocompetent Cells , 1973 .

[60]  J. Loutit,et al.  Treatment of Murine Leukaemia with X‐Rays and Homologous Bone Marrow: II , 1957, British journal of haematology.